Clinical research progress of traditional Chinese medicine in the treatment of children’s cold stagnation syndrome
- VernacularTitle:中医药治疗小儿感冒夹滞证的临床研究进展
- Author:
Weiqi LYU
1
;
Jinhai YI
2
;
Xingfang QIAO
1
Author Information
1. Sichuan-Chongqing Joint Key Laboratory of Innovation of New Drugs of Traditional Chinese Medicine，Chongqing Academy of Chinese Materia Medica，Chongqing 400065，China
2. Sichuan-Chongqing Joint Key Laboratory of Innovation of New Drugs of Traditional Chinese Medicine，Sichuan Academy of Chinese Medicine Sciences，Chengdu 610041，China
- Publication Type:Journal Article
- Keywords:
children;
cold stagnation syndrome;
traditional Chinese medicine;
etiology;
pathogenesis;
clinical research
- From:
China Pharmacy
2025;36(11):1411-1416
- CountryChina
- Language:Chinese
-
Abstract:
The changes in modern children’s lifestyles and dietary environments have led to children’s cold stagnation syndrome becoming one of the most common pediatric conditions. Traditional Chinese medicine attributes its internal causes primarily to lung-spleen deficiency and weak defensive functions， while external causes predominantly involve invasion by external pathogens such as wind or epidemic qi. The pathogenesis involves either initial food stagnation followed by external contraction or primary external contraction leading to secondary stagnation. Traditional Chinese medicine employs a syndrome differentiation and treatment system， utilizing targeted approaches such as internal therapies （Chinese herbal formulas or patent medicines， such as Youke shengjiang decoction， modified Dayuanyin formula， Huanghua shuangjie decoction， Sanyang qingjie decoction， Banxia xiexin decoction， Xiao’er chiqiao qingre granule， Baoji oral liquid， etc.）， external therapies （massage， acupuncture， acupoint applications）， combined therapies （integrating internal-external treatments or Chinese-Western medicine）， and preventive therapy at the pre-disease stage. These methods demonstrate unique advantages in alleviating clinical symptoms and improving treatment efficacy. However， limitations persist， including insufficient standardization in clinical research and a lack of in-depth mechanistic studies.
